Next Article in Journal
Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
Next Article in Special Issue
Pediatric Thyroid Cancer: To Whom Do You Send the Referral?
Previous Article in Journal
Minimal Residual Disease in Multiple Myeloma: Something Old, Something New
Previous Article in Special Issue
Laryngeal Neural Monitoring during Pediatric Thyroid Cancer Surgery—Is Transcartilage Recording a Preferable Method?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Recurrent Laryngeal Nerve Preservation Strategies in Pediatric Thyroid Oncology: Continuous vs. Intermittent Nerve Monitoring

1
Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, University Hospital, 06120 Halle, Germany
2
Section of Endocrine Surgery, Department of General, Visceral and Transplantation Surgery, University of Duisburg-Essen, 45147 Essen, Germany
*
Author to whom correspondence should be addressed.
Cancers 2021, 13(17), 4333; https://doi.org/10.3390/cancers13174333
Submission received: 18 June 2021 / Revised: 18 August 2021 / Accepted: 23 August 2021 / Published: 27 August 2021
(This article belongs to the Special Issue Innovations in the Integrated Management of Pediatric Thyroid Cancer)

Abstract

:

Simple Summary

Thyroid operations in children are difficult because children have thinner nerves than adults, and there is less space for the surgeon to operate. Since it runs closely behind the thyroid capsule, the nerve innervating the vocal cords can be injured during the operation. In thyroid cancer, the thyroid gland typically needs to be removed completely, putting the nerve at greater risk of injury. This surgical risk can be reduced by monitoring the function of the nerve before it is lastingly damaged. There are two methods to achieve this: intermittent (longer intervals between pulses) and continuous (very small intervals between pulses) nerve stimulation. In this study of 258 children with suspected or confirmed thyroid cancer, nerve damage and vocal cord palsy were observed only after intermittent and not after continuous nerve stimulation. This demonstrated that continuous nerve stimulation was safer than intermittent nerve stimulation.

Abstract

(1) Background: Pediatric thyroidectomy is characterized by considerable space constraints, thinner nerves, a large thymus, and enlarged neck nodes, compromising surgical exposure. Given these challenges, risk-reduction surgery is of paramount importance in children, and even more so in pediatric thyroid oncology. (2) Methods: Children aged ≤18 years who underwent thyroidectomy with or without central node dissection for suspected or proven thyroid cancer were evaluated regarding suitability of intermittent vs. continuous intraoperative neuromonitoring (IONM) for prevention of postoperative vocal cord palsy. (3) Results: There were 258 children for analysis, 170 girls and 88 boys, with 486 recurrent laryngeal nerves at risk (NAR). Altogether, loss of signal occurred in 2.9% (14 NAR), resulting in six early postoperative vocal cord palsies, one of which became permanent. Loss of signal (3.5 vs. 0%), early (1.5 vs. 0%), and permanent (0.3 vs. 0%) postoperative vocal cord palsies occurred exclusively with intermittent IONM. With continuous nerve stimulation, sensitivity, specificity, positive and negative predictive values, and accuracy reached 100% for prediction of early and permanent postoperative vocal cord palsy. With intermittent nerve stimulation, sensitivity, specificity, positive and negative predictive values, and accuracy were consistently lower for prediction of early and permanent postoperative vocal cord palsy, ranging from 78.6% to 99.8%, and much lower (54.2–57.9%) for sensitivity. (4) Conclusions: Within the limitations of the study, continuous IONM, which is feasible in children ≥3 years, was superior to intermittent IONM in preventing early and permanent postoperative vocal cord palsy.

1. Introduction

The operative morbidity of pediatric thyroid surgery is well defined for various age groups of children who undergo thyroidectomy at a tertiary referral center for Graves’ disease [1], papillary and medullary thyroid cancer [2], and neoplastic C-cell disease associated with multiple endocrine neoplasia type 2 [3]. Pediatric thyroidectomy is characterized by considerable space constraints, thinner nerves, a large thymus, and enlarged neck nodes, compromising surgical exposure.
In pediatric thyroid oncology, removal of all thyroid cancer from the neck frequently requires extensive dissection around the recurrent laryngeal nerve, increasing the risk of injury when embarked on by an inexperienced surgeon [4]. Breathing and swallowing greatly impact on health-related quality of life, which, if impaired, become a pain point for affected children and their parents [5,6]. Given these challenges, surgical risk reduction is of paramount importance in children. This is even more important when surgery is the mainstay of therapy, as in thyroid cancer. For risk minimization, the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS) jointly advocate intraoperative neuromonitoring (IONM) [7].
Recently, continuous IONM was shown to measure nerve electrophysiology more accurately than intermittent IONM during thyroidectomy for mostly benign thyroid conditions in children, regardless of age [6]. No such data has been put forward for children with oncological thyroid conditions. The present investigation aimed to evaluate the performance of intermittent vs. continuous IONM on early and permanent postoperative vocal cord palsy in this high-risk group of children.

2. Methods

2.1. Study Design

Included in this comparative study were all children aged ≤18 years who underwent thyroidectomy with or without central node dissection for suspected or proven thyroid cancer between May 1998 and April 2021 at the authors’ institution. Written informed consent was obtained for all procedures, which represented the standard of care in Germany [8].
A total of 4 consultant surgeons, each with an annual surgical volume of more than 150 thyroid procedures, operated on the children following the same standard approach. All procedures were carried out using 2.5–3.5-fold optical magnification and conventional bipolar diathermy. Intermittent IONM, routinely employed from the beginning of the study, was gradually superseded by continuous IONM in 2011, and largely phased out after 2012, filling a niche when continuous IONM equipment was unsuited for infants and small children or refused to work properly [6]. All children underwent intraoperative neuromonitoring with standardized stimulation of the vagus nerve and recurrent laryngeal nerve before and after resection [9].
Each child had preoperative laryngeal exams, typically within several weeks of surgery, and postoperative laryngeal exams 2 days after surgery [10]. Abnormal postoperative laryngeal exams were repeated regularly until they became normal. Postoperative vocal cord palsies failing to resolve within 6 months were considered as permanent.
For retrospective analysis of existing data sets from routine clinical care, no institutional review board approval was required under national law and applicable institutional regulations.

2.2. Setting of the Neuromonitoring Equipment

The setting of intermittent and continuous IONM equipment, described in more depth elsewhere [5,6,11,12,13], can be briefly summarized as follows:
For intermittent IONM, standard handheld monopolar stimulation probes, the Neurosign 100™ system (Inomed GmbH, Emmendingen, Germany), and the NIM-response® 2.0 and NIM-response® 3.0 neuromonitoring systems (Medtronic, Jacksonville, FL, USA) were used (4.0 Hz, 100 µs, 1 mA). Beginning in October 2003, electromyographic (EMG) signals generated by stimulation of the ipsilateral vagal nerve were recorded via tube electrodes for quantitative analysis.
For continuous IONM, the Automatic Periodic Stimulation (APS®) circumferential clip electrode was employed together with a standard handheld monopolar stimulation probe (Medtronic, Jacksonville, FL, USA) (4.0 Hz, 100 µs, 1 mA), the NIM-response® 3.0 with a pulse generator for continuous stimulation (1.0 Hz, 100 µs, 1 mA), and an EMG amplifier.
Stable evoked potentials from the vocal muscles were registered via endotracheal tube surface electrodes (NIM Standard Reinforced EMG Endotracheal Tube and NIM Contact Reinforced EMG Endotracheal Tube, Medtronic, Jacksonville, FL, USA). If necessary, the anesthetist was asked to reposition the tracheal tube to maximize the signal amplitude to at least 500 μV.

2.3. Statistical Analysis

All clinical and electrophysiological data were prospectively registered using Microsoft® SQL Server 2016 (Redmond, Washington, DC, USA).
For statistical analysis, the software package SPSS® version 25.0 (IBM, Armonk, New York, NY, USA) was used. Categorical data were tested with the two-tailed chi-square test, and are presented as absolute numbers with percentages. If the test reached the significance level of p < 0.05, correction for multiple testing was performed according to Bonferroni [14]. Continuous data were compared with the two-tailed Mann–Whitney–Wilcoxon rank sum test, and are displayed as median (interquartile range).
Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated as follows: Sensitivity equals predicted vocal cord palsies divided by the sum of true positive and false negative EMG signals. Specificity equals true negative results divided by the sum of true negative and false positive results. PPV equals true positive results divided by the sum of true positive and false positive results. NPV equals true negative results divided by the sum of true negative and false negative results. Accuracy equals the sum of true positive and true negative results divided by all tests performed.

3. Results

3.1. Demographics, Thyroid Histopathology, Extent, Type, and Completeness of Pediatric Oncological Thyroidectomy by Types of Intraoperative Nerve Stimulation and Recording Electrodes

There were 258 consecutive children for analysis, 170 girls and 88 boys, with 486 recurrent laryngeal nerves at risk (NAR).
When grouped by type of intraoperative nerve stimulation (Table 1), the 210 patients with intermittent stimulation (404 NAR) were, by and large, comparable to the 48 patients with continuous stimulation (82 NAR), barring few exceptions. After correction for multiple testing, significant differences remained regarding disease spectrum (decrease of hereditary medullary thyroid cancer from 33.8 to 8.3%), primary tumor diameter (medians of 1.3 vs. 2.5 mm), and concomitant use of tube electrodes (40.5 vs. 100%), reflecting temporal trends. Temporal shifts in the age distribution in the use of intermittent versus continuous IONM between January 1998 and April 2021 are shown in Figure 1.
When grouped by type of recording electrodes (Table 2), the 125 children with needle electrodes (244 NAR) differed in many ways from the 133 children with tube electrodes (242 NAR), most of which reflected temporal trends in terms of age at thyroidectomy (medians of 12.0 vs. 14.0 years; fewer children ≤6 years and more children >12 years had tube electrodes), disease spectrum (decrease of hereditary medullary thyroid cancer from 43.2 to 15.8% and increase of papillary thyroid cancer from 34.4 to 66.2%), primary tumor diameter (medians of 0.4 vs. 2.1 mm), extent of neck surgery (increase of less than total thyroidectomies with central node dissection from 16.8 to 34.6%, paralleled by reduction of total thyroidectomies with central node dissection from 66.4 to 46.6%), and concomitant use of continuous nerve stimulation (0 vs. 36.1%).
All in all, there were one postoperative hemorrhage (0.8%) and one wound infection (0.8%), each of which necessitated reoperation (data not shown).

3.2. Intraoperative Loss of the EMG Signal and Postoperative Vocal Cord Palsy in Children with Normal Preoperative Vocal Cord Function

A total of 486 NAR were intraoperatively monitored, 14 of which (2.9%) revealed loss of the EMG signal. This resulted in six early unilateral postoperative nerve palsies, one of which became permanent.
When grouped by type of intraoperative nerve stimulation (Table 3, upper panel), only children with intermittent nerve stimulation experienced loss of the EMG signal (3.5 vs. 0%) and early (1.5 vs. 0%) and permanent (0.3 vs. 0%) postoperative vocal cord palsies, with loss of signal trending towards statistical significance (p = 0.087). Temporal shifts in the number of intact vocal cord function and early postoperative vocal fold palsies in the use of intermittent versus continuous IONM between January 1998 and April 2021 are shown in Figure 2.
When grouped by type of recording electrodes (Table 3, lower panel), children with needle electrodes sustained loss of the EMG signal (3.3 vs. 2.5%) and early (1.6 vs. 0.8%) and permanent (0.4 vs. 0%) postoperative vocal cord palsies slightly more often than children with tube electrodes.

3.3. Characterization of Children with Postoperative Vocal Cord Palsies

Loss of the EMG signal and postoperative vocal cord palsies were seen with intermittent nerve stimulation only.
Altogether, four early postoperative vocal cord palsies (three on the left and one on the right) occurred after primary operation for hereditary C-cell disease, one of which became permanent (Table 4). Conversely, two early postoperative vocal cord palsies (one on either side) were noted after completion of neck surgery for hereditary medullary and follicular thyroid cancer, respectively.
Taken together, early vocal cord palsy affected 4 (2.3%) of 172 children ≤10 years of age (among all 208 children), as compared with 2 (0.9%) of 232 children >10 years of age (among all 278 children) with intermittent nerve stimulation, but this association was nonsignificant (p = 0.234; p = 0.229) for all children.
It was interesting to note that it was the child with the most advanced tumor (extrathyroid extension, 23 dissected node metastases, and microscopically involved surgical margins) who developed the only permanent postoperative vocal cord palsy.

3.4. Prediction of Early and Permanent Postoperative Vocal Cord Palsy by Types of Intraoperative Nerve Stimulation and Recording Electrodes

For technical evaluation of the performance of IONM, all recurrent laryngeal nerves were considered, whether preoperatively functioning or not or subsequently resected for oncological reasons. Due to this, 26 (instead of 6) early and 21 (instead of 1) permanent postoperative vocal cord palsies were available for evaluation.
With continuous nerve stimulation, sensitivity, specificity, positive and negative predictive values, and accuracy reached 100% for prediction of early and permanent postoperative vocal cord palsy (Table 5, left column).
With intermittent nerve stimulation, sensitivity, specificity, positive and negative predictive values, and accuracy were consistently lower for prediction of early and permanent postoperative vocal cord palsy, ranging from 78.6% to 99.8%, and much lower (54.2–57.9%) for sensitivity (Table 5, right column).
In the comparative analysis of the recording tubes, sensitivity, specificity, and positive and negative predictive values for prediction of early and permanent postoperative vocal cord palsy were variable, without a clear pattern favoring one electrode type over the other (Table 6).

4. Discussion

This is the largest and most comprehensive study and first of its kind to compare intermittent with continuous monitoring of recurrent laryngeal nerve function in pediatric thyroid surgical oncology. The present work was noteworthy for the large number of infants and small children who underwent neck surgery for hereditary C-cell disease. Remarkably, not a single instance of loss of signal, or early or permanent postoperative vocal fold palsy, was noted (based on 82 nerves at risk) during or after continuous nerve monitoring, as opposed to intermittent nerve monitoring.
These results were consistent with the findings of a recent study of 6029 mostly adult patients with mainly benign thyroid disease in which continuous IONM independently reduced early postoperative vocal cord palsy 1.8-fold and permanent postoperative vocal cord palsy 29.4-fold compared with intermittent IONM [13]. This study found 1 permanent vocal cord palsy per 75.0 early postoperative vocal cord palsies with continuous IONM (based on 5208 nerves at risk), as compared with 1 permanent vocal cord palsy per 4.2 early postoperative vocal cord palsies after intermittent IONM (based on 5024 nerves at risk). The present findings support the notion that these adult data are applicable to children with pediatric thyroid oncology as well.
Impending recurrent laryngeal nerve injury is preceded by combined events in the EMG tracing, which combine amplitude decreases >50% with latency increases >10% relative to baseline (Figure 3) [11]. Most nerve injuries are caused by traction on the recurrent laryngeal nerve, which is commonly reversible upon immediate release of the nerve [15,16]. Real-time detection of nerve injuries as they unfold enables prompt reversal of causative maneuvers during the operation. This competitive advantage is the unique selling point of continuous IONM in experienced hands, giving it a lead over intermittent IONM [13].
Previous research suggested that this competitive edge applies to children as well [6]. When continuous nerve stimulation was used, median baseline amplitudes augmented with the child’s age. This was likely due to better device connectivity (reduced resistance between electrodes and effector) in older children, in whom the mismatch in size between the APS® electrode and the vagus nerve is diminished. Likewise, median latency became larger with increasing age of the child, and thus the length of the monitored vagus/recurrent laryngeal nerve axis, which increase was greater on the left side where the recurrent laryngeal nerve takes a longer course beneath the aortic arch [6].
The present data, deriving from a high-risk group of children who underwent surgery for thyroid cancer and hereditary C-cell disease, confirm and extend these findings.
For children aged <10 years, the American Thyroid Association management guidelines for children with thyroid nodules and differentiated thyroid cancer advocate consideration of the use of IONM, despite the lack of pertinent data [17]. Subsequently, it was reported that the risk of postoperative vocal fold palsy does not increase in children of younger age groups when pediatric thyroidectomy was performed in infants and young children by experienced high-volume surgeons [1,2]. These findings may not equally extend to other clinical settings [18]. By way of contrast, a recent study of 113 patients with 183 nerves at risk found that the risk of nerve injury was increased in children <10 years of age, especially in the context of thyroid cancer and concomitant central neck dissection [19]. In the present study, four of our six patients who developed early postoperative vocal cord palsy were aged ≤10 years, but this difference was not statistically significant (Table 4).
The relatively large size of commercially available endotracheal tubes with integrated reporting electrodes, featuring inner diameters of ≥5.0 mm, is an obstacle to the use of IONM in children under 3 years of age (Figure 4). For very young children under the age of 3 years, the use of needle electrodes can be a viable option. Needle electrodes, if displaced, are quickly spotted and easily repositioned because they are located inside the operating field [20]. Adhesive electrodes can also be fitted onto generic endotracheal 3.0 or 4.0 tubes under the premise that utmost caution is exercised to avoid a mismatch between cuff and tip of the endotracheal tube. Such mismatch increases the risk of injury to tracheal mucosa and wall, and may jeopardize maintenance of the pediatric airway.
Congruent with other research in the field, this study was limited by the use of two risk-minimization strategies at the same time, visual nerve identification and IONM. Both strategies jointly represent a standard of care in Germany [13]. As a result, the independent contribution of each method cannot be separated.
When a novel technology is introduced into clinical practice, there typically is a learning curve that may affect results. As an institutional standard, intermittent IONM was well established, whereas continuous IONM was still an emerging technology at its introduction at the authors’ institution in 2011. However, it was this novel technology, not the established standard of care, that was associated with lower, not higher, rates of early postoperative and permanent vocal cord palsy.
Further limitations, inherent in research into a rare disease, included the long study period and the low event rate of postoperative vocal cord palsy at the authors’ referral center. Although levels of institutional standardization and staff continuity (four consultant surgeons in total) were unusually high, subtle improvements in surgical skills over the study period cannot be entirely excluded.
To add another layer of complexity, children do not really form a homogeneous group of people. Biologically, it may be worthwhile to subdivide children into newborns, infants, preschool children, school children, and adolescents. This line of reasoning is buttressed by the difficulty of fitting children aged <3 years with commercial endotracheal tubes with integrated reporting electrodes necessitated the use of needle electrodes for intermittent nerve stimulation in the early years of the study. Younger children also tend to have their thymus preserved more often than older children, exacerbating surgical space constraints.
However, when it comes to subdividing a small group of people with infrequent disease and rare clinical outcomes, statistical issues immediately come to the fore. In fact, pediatric research is almost always hampered by low numbers of study participants and the infrequency of clinical outcomes, diminishing statistical power and hindering evidence generation for children.
Hereditable C-cell disease also is more frequent in young children, whereas papillary and follicular thyroid cancers preferentially affect older children. In addition, thyroid cancer encompasses a wide disease spectrum, ranging from node-negative tumors (C-cell disease and follicular thyroid cancer) to regionally advanced node-positive tumors (papillary and medullary thyroid cancer). By implication, extent of disease and extent of node dissection were required to match up. The independent effects of these interdependencies between age and thyroid disease are difficult, if not impossible, to unravel.
A key strength of this investigation was the high level of standardization with rigorous control of preoperative and postoperative vocal fold function. However, the present findings were obtained at a high-volume tertiary referral center for pediatric and adult oncologic surgery. Outside specialist centers, the operative morbidity is likely to be considerably greater.

5. Conclusions

Within the limitations of this observational study, continuous IONM, which is feasible in children ≥3 years of age, was superior to intermittent IONM in preventing postoperative vocal cord palsy in pediatric thyroid oncology. When combined with the use of handheld stimulation probes to enhance nerve identification, continuous IONM is poised to become an integral part of pediatric thyroid cancer surgery. The authors of the present research use 3.5-fold optical magnification for children <3 years of age, and 2.5-fold optical magnification for older children to locate nerves, as well as the parathyroid glands, which are small, translucent, and not easy to distinguish in these children from adjacent tissues, thymus, and central neck nodes. Before terminating neck operations, the authors stimulate the vagus nerve one more time to confirm that the recurrent laryngeal nerve is working, and perform parathyroid hormone quick tests to determine upfront the adequacy of postoperative parathyroid function, which is paramount to infants and small children. In light of this, it is prudent to have high-volume surgeons and a multidisciplinary team manage these children [6,18,21,22].

Author Contributions

Conceptualization, R.S., A.M.; methodology, R.S., K.L.; software, C.S.; data curation and validation, R.S., C.S., A.M., K.L., H.D.; formal analysis and interpretation; R.S., A.M., C.S., K.L., H.D.; writing—original draft preparation, R.S., A.M.; writing—review and editing, R.S., A.M., C.S., K.L., H.D.; supervision, H.D.; project administration, R.S.; funding acquisition, R.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Institutional Review Board Statement

Medical Association—Declaration of Helsinki—ethical principles for medical research. For retrospective analysis of existing data sets from routine clinical care, no institutional review board approval was required under national law and applicable institutional regulations.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data are not available.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Machens, A.; Elwerr, M.; Schneider, R.; Lorenz, K.; Dralle, H. Disease impacts more than age on operative morbidity in children with Graves’ disease after total thyroidectomy. Surgery 2018, 164, 993–997. [Google Scholar] [CrossRef]
  2. Machens, A.; Elwerr, M.; Thanh, P.N.; Lorenz, K.; Schneider, R.; Dralle, H. Impact of central node dissection on postoperative morbidity in pediatric patients with suspected or proven thyroid cancer. Surgery 2016, 160, 484–492. [Google Scholar] [CrossRef]
  3. Machens, A.; Elwerr, M.; Lorenz, K.; Weber, F.; Dralle, H. Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations. Br. J. Surg. 2018, 105, e150–e157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Wu, S.Y.; Shen, H.Y.; Duh, Q.Y.; Hsieh, C.B.; Yu, J.C.; Shih, M.L. Routine Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerve to Facilitate Complete Resection and Ensure Safety in Thyroid Cancer Surgery. Am. Surg. 2018, 84, 1882–1888. [Google Scholar] [CrossRef] [PubMed]
  5. Schneider, R.; Machens, A.; Randolph, G.; Kamani, D.; Lorenz, K.; Dralle, H. Impact of continuous intraoperative vagus stimulation on intraoperative decision making in favor of or against bilateral surgery in benign goiter. Best Pract. Res. Clin. Endocrinol. Metab. 2019, 33, 101285. [Google Scholar] [CrossRef] [PubMed]
  6. Schneider, R.; Machens, A.; Sekulla, C.; Lorenz, K.; Weber, F.; Dralle, H. Twenty-year experience of paediatric thyroid surgery using intraoperative nerve monitoring. Br. J. Surg. 2018, 105, 996–1005. [Google Scholar] [CrossRef] [PubMed]
  7. Stack, B.C., Jr.; Twining, C.; Rastatter, J.; Angelos, P.; Baloch, Z.; Diercks, G.; Faquin, W.; Kazahaya, K.; Rivkees, S.; Sheyn, T.; et al. Consensus Statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS) on Pediatric Benign and Malignant Thyroid Surgery. Endocr. Pract. 2021, 27, 174–184. [Google Scholar] [CrossRef] [PubMed]
  8. Dralle, H.; Musholt, T.J.; Schabram, J.; Steinmüller, T.; Frilling, A.; Simon, D.; Goretzki, P.E.; Niederle, B.; Scheuba, C.; Clerici, T.; et al. German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch. Surg. 2013, 398, 347–375. [Google Scholar]
  9. Randolph, G.W.; Dralle, H.; International Intraoperative Monitoring Study Group; Abdullah, H.; Barczynski, M.; Bellantone, R.; Brauckhoff, M.; Carnaille, B.; Cherenko, S.; Chiang, F.Y.; et al. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: International standards guideline statement. Laryngoscope 2011, 121, S1–S16. [Google Scholar] [CrossRef]
  10. Dionigi, G.; Boni, L.; Rovera, F.; Rausei, S.; Castelnuovo, P.; Dionigi, R. Postoperative laryngoscopy in thyroid surgery: Proper timing to detect recurrent laryngeal nerve injury. Langenbecks Arch. Surg. 2010, 395, 327–331. [Google Scholar] [CrossRef] [Green Version]
  11. Schneider, R.; Randolph, G.W.; Sekulla, C.; Phelan, E.; Thanh, P.N.; Bucher, M.; Machens, A.; Dralle, H.; Lorenz, K. Continuous intraoperative vagus nerve stimulation for identification of imminent recurrent laryngeal nerve injury. Head Neck 2013, 35, 1591–1598. [Google Scholar] [CrossRef] [PubMed]
  12. Schneider, R.; Sekulla, C.; Machens, A.; Lorenz, K.; Nguyen Thanh, P.; Dralle, H. Postoperative vocal fold palsy in patients undergoing thyroid surgery with continuous or intermittent nerve monitoring. Br. J. Surg. 2015, 102, 1380–1387. [Google Scholar] [CrossRef] [PubMed]
  13. Schneider, R.; Machens, A.; Sekulla, C.; Lorenz, K.; Elwerr, M.; Dralle, H. Superiority of continuous over intermittent intraoperative nerve monitoring in preventing vocal cord palsy. Br. J. Surg. 2021, 108, 566–573. [Google Scholar] [CrossRef]
  14. Bland, J.M.; Altman, D.G. Multiple significance tests: The Bonferroni method. BMJ 1995, 310, 170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Schneider, R.; Randolph, G.; Dionigi, G.; Barczyński, M.; Chiang, F.Y.; Triponez, F.; Vamvakidis, K.; Brauckhoff, K.; Musholt, T.J.; Almquist, M.; et al. Prospective study of vocal fold function after loss of the neuromonitoring signal in thyroid surgery: The International Neural Monitoring Study Group’s POLT Study. Laryngoscope 2016, 126, 1260–1266. [Google Scholar] [CrossRef] [PubMed]
  16. Schneider, R.; Randolph, G.; Dionigi, G.; Barczynski, M.; Chiang, F.Y.; Wu, C.W.; Musholt, T.; Uludag, M.; Makay, Ö.; Sezer, A.; et al. Prediction of postoperative vocal fold function after intraoperative recovery of loss of signal. The International Neuromonitoring Study Group’s PREC Study. Laryngoscope 2019, 129, 525–531. [Google Scholar] [CrossRef] [PubMed]
  17. Francis, G.L.; Waguespack, S.G.; Bauer, A.J.; Angelos, P.; Benvenga, S.; Cerutti, J.M.; Dinauer, C.A.; Hamilton, J.; Hay, I.D.; Luster, M.; et al. American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015, 25, 716–759. [Google Scholar] [CrossRef] [Green Version]
  18. Sosa, J.A.; Tuggle, C.T.; Wang, T.S.; Thomas, D.C.; Boudourakis, L.; Rivkees, S.; Roman, S.A. Clinical and economic outcomes of thyroid and parathyroid surgery in children. J. Clin. Endocrinol. Metab. 2008, 93, 3058–3065. [Google Scholar] [CrossRef]
  19. Ritter, A.; Hod, R.; Reuven, Y.; Shpitzer, T.; Mizrachi, A.; Raveh, E.; Bachar, G. Role of intraoperative recurrent laryngeal nerve monitoring for pediatric thyroid surgery: Comparative analysis. Head Neck 2021, 43, 849–857. [Google Scholar] [CrossRef]
  20. Legré, M.; Bois, E.; Bernard, S.; Teissier, N.; Van Den Abbeele, T. Recurrent laryngeal nerve monitoring during thyroidectomy and parathyroidectomy in children. Int. J. Pediatr. Otorhinolaryngol. 2020, 131, 109846. [Google Scholar] [CrossRef]
  21. Oliver, J.R.; Patel, K.N.; Chang, C.M.; Baldwin, C.K.; Brar, P.C.; Morris, L.G.T.; Givi, B. Lymph node metastases in pediatric medullary thyroid carcinoma. Surgery 2021, 170, 736–742. [Google Scholar] [CrossRef] [PubMed]
  22. Spinelli, C.; Strambi, S.; Rossi, L.; Elisei, R.; Massimino, M. Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age. Curr. Pediatr. Rev. 2016, 12, 280–285. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Age distribution of thyroid surgery per year by intermittent vs. continuous neuromonitoring (IIONM vs. CIONM), January 1998–April 2021.
Figure 1. Age distribution of thyroid surgery per year by intermittent vs. continuous neuromonitoring (IIONM vs. CIONM), January 1998–April 2021.
Cancers 13 04333 g001
Figure 2. Number of intact vocal cord functions and vocal fold palsies after thyroid surgery per year by intermittent vs. continuous neuromonitoring (IIONM vs. CIONM), January 1998–April 2021.
Figure 2. Number of intact vocal cord functions and vocal fold palsies after thyroid surgery per year by intermittent vs. continuous neuromonitoring (IIONM vs. CIONM), January 1998–April 2021.
Cancers 13 04333 g002
Figure 3. Electromyogram tracings with preset amplitude (blue line) and latency (dark green line) thresholds with automatic periodic stimulation at 1 Hz. (A) Normal electromyogram (amplitude of 663 µV and latency of 2.25 ms at baseline) heralding normal postoperative vocal cord function. (B) Definitive loss of signal (combined event) without intraoperative recovery, signaling an ipsilateral vocal cord palsy.
Figure 3. Electromyogram tracings with preset amplitude (blue line) and latency (dark green line) thresholds with automatic periodic stimulation at 1 Hz. (A) Normal electromyogram (amplitude of 663 µV and latency of 2.25 ms at baseline) heralding normal postoperative vocal cord function. (B) Definitive loss of signal (combined event) without intraoperative recovery, signaling an ipsilateral vocal cord palsy.
Cancers 13 04333 g003
Figure 4. Continuous intraoperative nerve stimulation in a 3.5-year-old girl with C-cell hyperplasia in the context of multiple endocrine neoplasia type 2A. (A) Fitted recording endotracheal tube surface electrodes (NIM Trivantage EMG Endotracheal Tube 5.0). (B) Intraoperative situs after complete mobilization and removal of thyroid gland and central neck nodes, with the monopolar APS® clip electrode riding on the right vagus. (C) Picture of the contiguous surgical specimen comprising both thyroid lobes and central node compartment. The circle identifies the monopolar APS® clip electrode; the hashtag the right common carotid artery; and the dashed line the midline; whereas T signifies the trachea; L/R the left/right thyroid lobe; and C1a/C1b the right/left central node compartment.
Figure 4. Continuous intraoperative nerve stimulation in a 3.5-year-old girl with C-cell hyperplasia in the context of multiple endocrine neoplasia type 2A. (A) Fitted recording endotracheal tube surface electrodes (NIM Trivantage EMG Endotracheal Tube 5.0). (B) Intraoperative situs after complete mobilization and removal of thyroid gland and central neck nodes, with the monopolar APS® clip electrode riding on the right vagus. (C) Picture of the contiguous surgical specimen comprising both thyroid lobes and central node compartment. The circle identifies the monopolar APS® clip electrode; the hashtag the right common carotid artery; and the dashed line the midline; whereas T signifies the trachea; L/R the left/right thyroid lobe; and C1a/C1b the right/left central node compartment.
Cancers 13 04333 g004
Table 1. Demographics, thyroid histopathology, extent, type, and completeness of pediatric oncological thyroidectomy by type of intraoperative nerve stimulation.
Table 1. Demographics, thyroid histopathology, extent, type, and completeness of pediatric oncological thyroidectomy by type of intraoperative nerve stimulation.
VariablesTotal (258 Children;
486 Nerves at Risk)
Intermittent
Nerve Stimulation
(210 Children;
404 Nerves at Risk)
Continuous
Nerve Stimulation
(48 Children;
82 Nerves at Risk)
p
Sex, male8834.16932.91939.60.375
Age at operation, years, median (range)13.0(7.0; 16.0)13.0(7.0; 16.0)12.5(9.0; 15.0)0.765
Age at operation, years
   ≤3187.0167.624.20.086
   4–63614.03315.736.3
   7–127027.15124.31939.6
   13–1813451.911052.42450.0
Type of neoplastic condition
   Hereditary C-cell hyperplasia3513.62411.41122.90.036
   Medullary thyroid cancer7529.17133.848.3<0.001 *
   Papillary thyroid cancer13150.810349.02858.30.246
   Follicular thyroid cancer124.783.848.30.179
   Thyroid metastases from other cancers51.941.912.10.935
Largest primary tumor diameter, mm, median (range) (based on 153 children)1.6(0.3; 2.6) 1.3(0.2; 2.5)2.5(1.5; 3.9)<0.001 *
Extent of neck surgery
   Less than total thyroidectomy without
   central neck dissection
83.173.312.10.160
   Less than total thyroidectomy with central
   neck dissection
6726.05526.21225.0
   Total thyroidectomy without central neck
   dissection
3814.72612.41225.0
   Total thyroidectomy with central neck
   dissection
14556.212258.12347.9
Type of surgery
   Primary surgery17065.913262.93879.20.032
   Reoperation8834.17837.11020.8
Resectional status (based on 163 children)
   Complete (R0)15192.611891.53397.10.376
   Microscopically incomplete (R1)84.975.412.9
   Grossly incomplete (R2)42.543.100
Number of cleared nodes on central neck dissection, median (range) (based on 212 children)7(1; 16)8(2; 16)6(0; 13)0.125
Number of cleared nodes on central neck dissection (based on 212 children)
   ≤55325.04525.4822.90.622
   6–105124.14022.61131.4
   11–153315.62715.3617.1
   16–202813.22514.138.6
   >204722.24022.6720.0
Type of recording electrode used
   Needle electrode12548.412559.500<0.001 *
   Tube electrode13351.68540.548100
* After Bonferroni correction for multiple testing.
Table 2. Demographics, thyroid histopathology, extent, type, and completeness of pediatric oncological thyroidectomy by type of recording electrodes.
Table 2. Demographics, thyroid histopathology, extent, type, and completeness of pediatric oncological thyroidectomy by type of recording electrodes.
VariablesTotal (258 Children;
486 Nerves at Risk)
Needle Electrode
(125 Children;
244 Nerves at Risk)
Tube Electrode
(133 Children;
242 Nerves at Risk)
p
Sex, male8834.14132.84735.30.667
Age at operation, years, median (range)13.0(7.0; 16.0)12.0(6.0; 15.0)14.0(10.0; 16.0)<0.001 *
Age at operation, years
   ≤3187.0129.664.50.001 *
   4–63614.02419.2129.0
   7–127027.13628.83425.6
   13–1813451.95342.48160.9
Type of neoplastic condition
   Hereditary C-cell hyperplasia3513.62016.01511.30.268
   Medullary thyroid cancer7529.15443.22115.8<0.001 *
   Papillary thyroid cancer13150.84334.48866.2<0.001 *
   Follicular thyroid cancer124.764.864.50.912
   Thyroid metastases from other cancers51.921.632.30.703
Largest primary tumor diameter, mm, median (range) (based on 153 children)1.6(0.3; 2.6)0.4(0.2; 2.0)2.1(1.0; 3.2)<0.001 *
Extent of neck surgery
   Less than total thyroidectomy without
   central neck dissection
83.143.243.00.990
   Less than total thyroidectomy with
   central neck dissection
6726.02116.84634.6<0.001 *
   Total thyroidectomy without central neck
   dissection
3814.71713.62115.80.768
   Total thyroidectomy with central neck
   dissection
14556.28366.46246.6<0.001 *
Type of surgery
   Primary surgery17065.99072.08060.20.045
   Reoperation8834.13528.05339.8
Resectional status (based on 163 children)
   Complete (R0)15192.66894.48391.20.259
   Microscopically incomplete (R1)84.934.255.5
   Grossly incomplete (R2)42.511.433.3
Number of cleared nodes on central neck dissection, median (range) (based on 212 children)7(1; 16)7(2; 16)8(1; 17)0.815
Number of cleared nodes on central neck dissection, number (based on 212 children)
   ≤55325.02826.92523.10.098
   6–105124.12524.02624.1
   11–153315.61514.41816.7
   16–202813.21918.398.3
   >204722.21716.33027.8
Type of nerve stimulation used
   Intermittent21081.41251008563.9<0.001 *
   Continuous4818.6004836.1
* After Bonferroni correction for multiple testing.
Table 3. Intraoperative loss of the EMG signal and postoperative vocal cord palsy in children with normal preoperative vocal cord function.
Table 3. Intraoperative loss of the EMG signal and postoperative vocal cord palsy in children with normal preoperative vocal cord function.
A. Type of Intraoperative Nerve Stimulation
VariablesTotal
(486 Nerves
at Risk)
Intermittent
(404 Nerves
at Risk)
Continuous
(82 Nerves
at Risk
p
Loss of the EMG signal142.9143.5000.087
Early postoperative vocal cord palsy61.261.5000.267
Permanent postoperative vocal cord palsy10.210.3000.652
B. Type of Recording Electrodes
VariablesTotal
(486 Nerves
at Risk)
Needle Electrodes
(244 Nerves
at Risk)
Tube
Electrodes(242 Nerves
at Risk)
p
Loss of the EMG signal142.983.362.50.598
Early postoperative vocal cord palsy61.241.620.80.417
Permanent postoperative vocal cord palsy10.210.4000.319
EMG, electromyogram.
Table 4. Children with normal preoperative nerve function and early postoperative vocal cord palsy.
Table 4. Children with normal preoperative nerve function and early postoperative vocal cord palsy.
ChildThyroid HistopathologyNeck SurgeryIntraoperative Nerve StimulationPostoperative Vocal Cord Palsy
Age at TT *SexType of Neoplastic Condition
(AJCC/TNM Classification)
ExtentNo. of Involved NodesResectional StatusTypeLoss of EMG SignalSideTypeOutcome
3malehereditary MTC/MEN 2B
(pT1aN0M0)
TT, CND, LND0 of 91Complete (R0)intermittentnoneleftincompletetransient
4malehereditary CCH/MEN2ATT, CND0 of 2Complete (R0)intermittentnonerightin-completetransient
7malehereditary MTC/MEN2A (pT1aN1bM0)TT, CND, LND2 of 42Complete (R0)intermittentnoneleftcompletetransient
10femalehereditary MTC/MEN2A (T4bN1bM1)LND, MND for completion23 of 41Microscopically incomplete (R1)intermittenttype 2leftcompletepermanent
16femalehereditary MTC/MEN2A (pT1aN0M0)TT, CND0 of 8Complete (R0)intermittenttype 1leftcompletetransient
17femaleFTC
(pT3aN0M0)
TT, CND for completion0 of 19Complete (R0)intermittenttype 2leftcompletetransient
CCH, C-cell hyperplasia; CND, central neck dissection; EMG, electromyogram; FTC, follicular thyroid cancer; LND, lateral neck dissection; MTC, medullary thyroid cancer; MND, modified neck dissection; type 1, segmental loss of signal; type 2, global loss of signal; TT, total thyroidectomy. * 4 of 172 nerves at risk in children ≤10 years of age vs. 2 of 232 nerves at risk in children >10 years of age with intermittent nerve stimulation (p = 0.234).
Table 5. Prediction of early and permanent postoperative vocal cord palsy by type of intraoperative nerve stimulation.
Table 5. Prediction of early and permanent postoperative vocal cord palsy by type of intraoperative nerve stimulation.
Type of Intraoperative Nerve Stimulation
Early Postoperative Vocal Cord PalsyIntermittentContinuous
EMG Signal Per Nerve *EMG Signal Per Nerve **
NormalAbnormalTotalNormalAbnormalTotal
Absent397139882082
Present111324022
Total4081442282284
%95%CI%95%CIP
Sensitivity 54.2(34.2, 74.1)100(100, 100)0.621
Specificity 99.8(99.3, 100.2)100(100, 100)0.836
PPV 92.9(79.4, 106.3)100(100, 100)0.750
NPV 97.3(95.7, 98.9)100(100, 100)0.494
Accuracy 97.2(95.5, 98.8)100(100, 100)0.118
Permanent Postoperative Vocal Cord PalsyIntermittentContinuous
EMG Signal Per Nerve *EMG Signal Per Nerve **
NormalAbnormalTotalNormalAbnormalTotal
Absent400340382082
Present81119022
Total4081442282284
%95%CI%95%CIP
Sensitivity 57.9(35.7, 80.1)100(100, 100)0.244
Specificity 99.3(98.4, 100.1)100(100, 100)0.433
PPV 78.6(57.1, 100.1)100(100, 100)0.646
NPV 98.0(96.7, 99.4)100(100, 100)0.563
Accuracy 97.4(95.9, 98.9)100(100, 100)0.134
EMG, electromyogram; NPV, negative predictive value; PPV, positive predictive value. * Including preoperative vocal cord palsies and oncological recurrent laryngeal nerve resections to increase the number of outcome events from 6 early and 1 permanent to 24 early and 19 permanent postoperative vocal cord palsies. ** Including preoperative vocal cord palsies and oncological recurrent laryngeal nerve resections to increase the number of outcome events from 0 early and 0 permanent to 2 early and 2 permanent postoperative vocal cord palsies.
Table 6. Prediction of early and permanent postoperative vocal cord palsy by type of recording electrodes.
Table 6. Prediction of early and permanent postoperative vocal cord palsy by type of recording electrodes.
Type of Recording Electrodes
Early Postoperative
Vocal Cord Palsy
Needle ElectrodesTube Electrodes
EMG Signal Per Nerve *EMG Signal Per Nerve **
NormalAbnormalTotalNormalAbnormalTotal
Absent24002402391240
Present88165510
Total24882562446250
%95%CI%95%CIP
Sensitivity 50.0(25.5, 74.5)50.0(19.0, 81.0)>0.999
Specificity 100.0(0, 100.0)99.6(98.8, 100.4)0.316
PPV 100.0(100.0, 100.0)83.353.5, 113.2)0.259
NPV 96.8(94.6, 99.0)98.0(96.2, 99.7)0.415
Accuracy 96.9(94.7, 99.0)97.6(95.7, 99.5)0.619
Permanent Postoperative
Vocal Cord Palsy
Needle ElectrodesTube Electrodes
EMG Signal Per Nerve *EMG Signal Per Nerve **
NormalAbnormalTotalNormalAbnormalTotal
Absent24212432402242
Present6713448
Total24882562446250
%95%CI%95%CIP
Sensitivity 53.9(26.7, 80.9)50.0(15.4, 84.6)0.864
Specificity 99.6(98.8, 100.4)99.2(98.0, 100.3)0.560
PPV 87.5(64.6, 110.4)66.7(28.9, 104.4)0.375
NPV 97.6(95.7, 99.5)98.4(96.8, 100.0)0.538
Accuracy 97.3(95.2, 99.3)97.6(95.7, 99.5)0.812
EMG, electromyogram; NPV, negative predictive value; PPV, positive predictive value. * Including preoperative vocal cord palsies and oncological recurrent laryngeal nerve resections to increase the number of outcome events from 4 early and 1 permanent to 16 early and 13 permanent postoperative vocal cord palsies. ** Including preoperative vocal cord palsies and oncological recurrent laryngeal nerve resections to increase the number of outcome events from 2 early and 0 permanent to 10 early and 8 permanent postoperative vocal cord palsies.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Schneider, R.; Machens, A.; Sekulla, C.; Lorenz, K.; Dralle, H. Recurrent Laryngeal Nerve Preservation Strategies in Pediatric Thyroid Oncology: Continuous vs. Intermittent Nerve Monitoring. Cancers 2021, 13, 4333. https://doi.org/10.3390/cancers13174333

AMA Style

Schneider R, Machens A, Sekulla C, Lorenz K, Dralle H. Recurrent Laryngeal Nerve Preservation Strategies in Pediatric Thyroid Oncology: Continuous vs. Intermittent Nerve Monitoring. Cancers. 2021; 13(17):4333. https://doi.org/10.3390/cancers13174333

Chicago/Turabian Style

Schneider, Rick, Andreas Machens, Carsten Sekulla, Kerstin Lorenz, and Henning Dralle. 2021. "Recurrent Laryngeal Nerve Preservation Strategies in Pediatric Thyroid Oncology: Continuous vs. Intermittent Nerve Monitoring" Cancers 13, no. 17: 4333. https://doi.org/10.3390/cancers13174333

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop